X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer

The allure of potentially dramatic and durable responses to immunotherapy has driven the study of several immune checkpoint inhibitor (ICI) agents in ovarian cancer. However, the results of ICI therapy in ovarian cancer have been rather disappointing. It is important to understand the reasons for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yanhui, Yang, Lewei, Jiang, Ling, Yu, Wenyan, Jin, Zhongwen, Qiu, Yeqing, Liao, Yifeng, Liu, Jihong, Zhang, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386150/
https://www.ncbi.nlm.nih.gov/pubmed/35991556
http://dx.doi.org/10.3389/fgene.2022.818917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386150/
https://www.ncbi.nlm.nih.gov/pubmed/35991556
http://dx.doi.org/10.3389/fgene.2022.818917

Ejemplares similares